CureSearch offers the following annual grant opportunities in pediatric cancer research designed to feed each phase of the drug development pipeline. Our 2016 application window for these programs has closed. Please refer to our 2016 program guidelines and request for applications for general details. Requests for applications for the 2017 cycle will be released as indicated below.
Young Investigator Program
The Young Investigator Program is intended to encourage promising scientists to enter into the field of pediatric cancer research by providing significant financial support to investigators early in their research career. These grants are limited to truly transformational science designed to deliver the next generation of cancer treatment. The Young Investigator Program feeds our drug development pipeline by recruiting and supporting the best and the brightest young scientists to make a difference right from the start of their career.
The next Young Investigator Award application window will open in March 2017.
The Acceleration Initiative elicits and invests in the best, most innovative pediatric cancer research and feeds the drug development pipeline by supporting projects with the following characteristics:
- Highly innovative with the potential to break new ground in the field
- Probability of clinical application (i.e. ready to reach patients within 3 years — an accelerated time frame)
- Help overcome scientific and therapeutic roadblocks to speed up the delivery of promising interventions (i.e. transcends a broken system to end childhood cancer) by addressing challenge areas identified by our scientific advisory council
The AI program is intended for established investigators and encourages collaborative teams in basic and clinical research. Partnerships and collaborations with industry are highly encouraged. In addition to scientific merit, applications will be evaluated for their scientific merit as well as their clinical drug development and commercialization potential. Grants are awarded for three years with a typical budget of $1M per year.
The current Acceleration Initiative cycle for 2016, AI-3, is now closed. The 2016 RFA is available here. The next Acceleration Initiative application window will open in early Fall 2017.
The Catapult Fund is the third phase of our drug development pipeline. Catapult will propel discoveries over the Valley of Death and into clinical and commercial development. The Catapult Fund will provide funding support for late-preclinical (IND enabling studies) and “clinic-ready” projects to support the development of innovative, novel, and promising pediatric oncology research into early phase human clinical trials and product commercialization with the ultimate goal of improving clinical outcomes in childhood cancer patients. CureSearch has particular interest in collaborative projects and/or research which has out-licensed its technology, ie, through a start-up venture, or has an identified commercial partner.
The application window for a “Proof of Concept” project has closed. The 2016 RFA is available here. The Catapult Fund will begin accepting applications on a rolling basis in Spring 2017.
CureSearch Community Impact Awards (CCIA)
The CureSearch Community Impact Awards program recognizes the role of local hospitals in providing care and services to pediatric cancer patients and families. The CCIA program provides funding to local hospitals for psychosocial programs/resources that support families and pediatric cancer patients in coping with emotional, mental and other anxieties associated with cancer diagnosis, treatment and survivorship. Projects aim to improve behavioral and psychological outcomes for pediatric cancer patients.
The 2016 CCIA cycle is closed. The next CCIA application window will be announced in late Spring of 2017.
How to Apply
To apply for these grant programs, go to Proposal Central. For more details and specific application instructions for our active programs go to: https://proposalcentral.altum.com/opportunities.asp?GMID=51.
For more information about these grant opportunities or pediatric cancer research sponsored by CureSearch for Children’s Cancer, contact Sarita Sastry, PhD, National Director, Research and Programs, (240) 235-2215, email@example.com.